CAMBRIDGE, Mass. and CHICAGO, Dec. 19, 2023 /PRNewswire/ -- Shorla Oncology ('Shorla'), a U.S.-Ireland specialty pharmaceutical company, and EVERSANA®, a leading provider of commercialization services ...
Methotrexate works by inhibiting dihydrofolic acid reductase, which interferes with DNA synthesis, repair, and cellular replication. Silvergate announced the launch of Xatmep (methotrexate) Oral ...
To date, there is no approved oral liquid formulation of methotrexate for pediatric patients who require body surface area (BSA) dosing or who have difficulty swallowing or cannot ingest tablets or ...
Methotrexate The effectiveness of oral vs subcutaneous methotrexate for the treatment of psoriasis in a registry is reported. More patients with psoriasis who were treated with subcutaneous ...
Between 1986 and 2003, 43 eligible patients were identified, 29 female and 14 male, ranging in age from 32 years to 88 years at the time of diagnosis. The majority of patients were aged between 50 and ...
WOBURN, Mass., June 12, 2019 /PRNewswire/ — CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: ...
WOBURN, Mass.--(BUSINESS WIRE)--CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback